Welcome to our dedicated page for Core Scientific, Inc./tx SEC filings (Ticker: CORZZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Core Scientific, Inc./tx's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Core Scientific, Inc./tx's regulatory disclosures and financial reporting.
Form 144 filed for Core Scientific, Inc. (CORZZ) discloses an intended sale of 7,759 common shares through Fidelity Brokerage Services on 06/25/2025 via the Nasdaq.
- Aggregate market value: $96,141.77
- Shares outstanding: 297,821,835 (sale represents ~0.003%)
- Source of shares: Restricted-stock vesting on 06/24/2025, received as compensation
- Seller’s recent activity: 57,921 shares sold in the prior three months, generating $675,328.06 in gross proceeds
The filing is a routine notice required under Rule 144 and does not, by itself, alter Core Scientific’s fundamentals. However, it documents additional insider liquidity actions that investors may monitor for context on executive trading trends.